Manufacturing

Articles

Lonza’s investment in its Stein and Basel facilities in Switzerland aims to expand its overall drug product development and manufacturing services.

Lonza to Expand Capabilities at Manufacturing Sites in Switzerland

USAntibiotics will serve as the sole American-based provider of amoxicillin and amoxil clavulanate.

USAntibiotics Reopens Facility, Returning Antibiotic Production to the United States

Syngene’s additions include a new microbial facility and an expanded mammalian facility.

Syngene Expands Microbial and Mammalian Manufacturing Facilities in Bengalaru

Recro acquires CDMO IRISYS, establishing a bi-coastal presence in the US.

Recro Acquires IRISYS for $50 Million

Veraxa and Indivumed will work together to develop colorectal antibody drugs.

Veraxa and Indivumed Collaborate on Development of Precision Oncology Antibody Drugs

Syngene International appoints two US-based executives to senior level positions.

Syngene Announces Senior Level Appointments

VICO Therapeutics’ drug candidate, VO659, for treating Huntington’s Disease was granted orphan drug designation by FDA. 

FDA Grants Orphan Drug Designation to VICO Therapeutics for Huntington’s Disease Drug 

Kriya Therapeutics completes $100 Million Series B financing to advance its platform for designing, developing, and manufacturing gene therapies. 

Kriya Therapeutics to Advance Gene Therapies with $100 Million Financing 

BioNTech plans to expand its global footprint by establishing its regional headquarters for southeast Asia and a new mRNA manufacturing facility in Singapore. 

BioNTech to Establish Regional Headquarters and mRNA Manufacturing Facility in Singapore

The expanded agreement will include aseptic fill/finish services at its San Diego, CA facility.

Manufacturing, Drug Products